Susan Rutberg
Company: Sanofi
Job title: Director, Bioassays and Molecular Biology
Seminars:
Chair’s Closing Remarks & End of Day Two 4:50 pm
day: Day 2
Chair’s Opening Remarks 8:50 am
day: Day 2
ROUNDTABLE: Optimizing the Number of Potency Assays Performed to Accelerate Commercialization Without Draining Resources 2:45 pm
Roundtable discussions include a larger focus on group discussion. A moderator will introduce the session topic and attendees then split into groups to discuss a series of predetermined agenda points. At the end, all groups report back on their discussions, and findings are collated. This roundtable will cover: Meeting regulatory requirements for potency assessment The…Read more
day: Day 1
Parallel Line Analysis – How Can we Use it to Establish Relative Potency? 8:35 am
This interactive workshop delves into the critical aspect of determining relative potency in gene therapy potency assays. Relative potency assessment involves comparing the potency of a sample against a reference standard, crucial for ensuring the efficacy and safety of gene therapy products. The session aims to evaluate the different methods of analyzing dose-response curves and…Read more
day: Pre-conf day - Stream A